Zobrazeno 1 - 10 of 107 pro vyhledávání: '"Mp, Buisine"'
2
[MUC genes: a superfamily of genes? Towards a functional classification of human apomucins]
Autor: Porchet N, Mp, Buisine, Jean-Luc Desseyn, Moniaux N, Nollet S, Degand P, Pigny P, Van Seuningen I, Laine A, Jp, Aubert
Publikováno v: Europe PubMed Central
The MUC genes encode epithelial mucins. Eight different human genes have been well characterized, and two others identified more recently. Among them, a family of four genes, expressed in the respiratory and digestive tracts, is clustered to chromoso
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::02859c5dc88202ba76fd2768b32336ee
http://europepmc.org/abstract/med/10851560
Zobrazit plný text záznamu
3
Akademický článek
Comparison of the ABC and ACMG systems for variant classification.
Autor: Houge G; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway. gunnar.houge@helse-bergen.no., Bratland E; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Aukrust I; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Tveten K; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway., Žukauskaitė G; Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Sansovic I; Department of Medical and Laboratory Genetics, Endocrinology and Diabetology, Childrens' Hospital Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia., Brea-Fernández AJ; Grupo de Medicina Xenómica, Universidade de Santiago de Compostela, CIBERER), Santiago de Compostela, Spain., Mayer K; Center for Human Genetics and Laboratory Diagnostics, MVZ Martinsried GmbH, Martinsried, Germany., Paakkola T; Nordlab Wellbeing Service Group, Genetics Laboratory, Oulu, Finland., McKenna C; Northern Ireland Regional Molecular Diagnostic Service, Belfast, Northern Ireland., Wright W; Northern Ireland Regional Molecular Diagnostic Service, Belfast, Northern Ireland., Markovic MK; Center for Applied and Forensic Molecular Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia., Lildballe DL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Konecny M; Laboratory of Genomic Medicine, GHC GENETICS SK, Bratislava, Slovakia.; Department of Biology, Institute of Biology and Biotechnology, Faculty of Natural Sciences, University of ss. Cyril and Methodius in Trnava, Trnava, Slovakia., Smol T; Institut de Genetique Medicale-CHU Lille, Lille, France., Alhopuro P; HUS Diagnostic Center, Laboratory of Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Gouttenoire EA; MEDISYN Genetics, Chemin d'Entre-Bois 21, Lausanne, Switzerland., Obeid K; Molecular Diagnostics, Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Todorova A; Genetic Medico-Diagnostic Laboratory 'Genica' and Genome Center Bulgaria, Sofia, Bulgaria., Jankovic M; Neurology Clinic UCCS, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Lubieniecka JM; Humangenetik, Ruhr-Universität Bochum, Bochum, Germany., Stojiljkovic M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Buisine MP; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277, CANTHER, Lille, France., Haukanes BI; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Lorans M; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Roomere H; Department of laboratory genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia., Petit FM; Department of Oncopharmacology, Centre Antoine Lacassagne, Nice, France., Haanpää MK; Department of Genomics, Turku University Hospital, Turku, Finland., Beneteau C; CHU Bordeaux, Service de Génétique Médicale, F-33000, Bordeaux, France., Pérez B; Genetics Department of CEDEM, Universidad Autónoma de Madrid, Madrid, Spain., Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, North Macedonia., Rath M; Institute for Molecular Medicine, MSH Medical School Hamburg, Hamburg, Germany.; Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany., Fuhrmann N; Institute of Human Genetics, University of Cologne, Cologne, Germany., Ferreira BI; GENELAB by ABC, Faro, Portugal.; Faculty of Medicine and Biomedical Sciences, University of Algarve, Campus de Gambelas, Faro, Portugal., Stephanou C; Molecular Genetics Thalassemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Sjursen W; Department of Medical Genetics, St Olavs Hospital, Trondheim, Norway., Maver A; Clinical Institute of Genomic Medicine, Ljubljana, Slovenia., Rouzier C; Department of Medical Genetics, National Centre for Mitocondrial Diseases, CHU de NICE, Université Côte d'Azur, Nice, France.; CNRS, INSERM, IRCAN, Université Côte d'Azur, Nice, France., Chirita-Emandi A; Department of Microscopic Morphology Genetics Discipline, Center of Genomic Medicine, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Timisoara, Romania., Gonçalves J; Human Genetics Department, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Kuek WCD; Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, Kent Ridge, Singapore., Broly M; Laboratory of Rare and Autoinflammatory Genetic Diseases, Department of Genetics-LBM, Montpellier University Hospital, Montpellier, France., Haer-Wigman L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Thong MK; Genetics and Metabolism Unit, Department of Pediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Tae SK; Genetics and Metabolism Unit, Department of Pediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Hyblova M; Department of Genetics, Medirex, Bratislava, Slovakia., den Dunnen JT; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands., Laner A; Medizinisch Genetisches Zentrum (MGZ) München, Munich, Germany.
Publikováno v: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Jul; Vol. 32 (7), pp. 858-863. Date of Electronic Publication: 2024 May 22.
Zobrazit plný text záznamu
4
Akademický článek
AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Autor: Leclerc J; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Beaumont M; Laboratoire de Génétique Moléculaire et Génomique, CHU Rennes, Rennes, France., Vibert R; UF d'Oncogénétique Clinique, Département de Génétique et Institut Universitaire de Cancérologie, Hôpitaux Pitié-Salpêtrière et Saint-Antoine, AP-HP. Sorbonne Université, Paris, France., Pinson S; Human Genetics Department, Hospices Civils de Lyon, Lyon, France., Vermaut C; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Flament C; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Lovecchio T; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Delattre L; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Demay C; Bioinformatics Unit, Molecular Biology Facility, Lille University Hospital, Lille, France., Coulet F; Sorbonne University, INSERM, Saint-Antoine Research Center, Microsatellites instability and Cancer, CRSA, Genetics Department, AP-HP, Hôpital Pitié Salpêtrière, Sorbonne University, Paris, France., Guillerm E; Sorbonne University, INSERM, Saint-Antoine Research Center, Microsatellites instability and Cancer, CRSA, Genetics Department, AP-HP, Hôpital Pitié Salpêtrière, Sorbonne University, Paris, France., Hamzaoui N; Service de Génétique et Biologie Moléculaires, Hôpital Cochin, AP-HP Centre, Université de Paris, and INSERM UMR_S1016, Institut Cochin, Université de Paris, Paris, France., Benusiglio PR; UF d'Oncogénétique Clinique, Département de Génétique et Institut Universitaire de Cancérologie, Hôpitaux Pitié-Salpêtrière et Saint-Antoine, AP-HP. Sorbonne Université, Paris, France., Brahimi A; Clinique de Génétique, CHU Lille, Lille, France., Cornelis F; Department of Genetics-Oncogénétics-Prevention, Clermont-Ferrand Hospital, Clermont-Auvergne University, Clermont Ferrand, France., Delhomelle H; Department of Genetics, Curie Institute, Paris Sciences & Lettres Research University, Paris, France., Fert-Ferrer S; Centre Hospitalier Métropole Savoie, Chambéry, France., Fournier BPJ; Centre de Recherche des Cordeliers, University of Paris, Sorbonne University, INSERM UMRS 1138 - Molecular Oral Pathophysiology, Paris, France.; Dental Faculty Garanciere, Oral Biology Department, Centre of Reference for Oral and Dental Rare Diseases, AP-HP, University of Paris, Paris, France., Hovnanian A; INSERM UMR 1163 - Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France.; University of Paris, Paris, France.; Department of Genetics, Necker Hospital for sick children, AP-HP, Paris, France., Legrand C; Service de Génétique, Génomique et Procréation, CHU Grenoble Alpes, Grenoble, France., Lortholary A; Centre Catherine de Sienne, hôpital privé du Confluent, Nantes, France., Malka D; Department of Cancer Medicine, Gustave Roussy, Paris-Saclay University, INSERM UMR 1279 - Unité Dynamique des Cellules Tumorales, Villejuif, France., Petit F; Clinique de Génétique, CHU Lille, Lille, France.; Univ. Lille, EA7364 - RADEME, CHU Lille, Lille, France., Saurin JC; Hepatogastroenterology, E Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Lejeune S; Clinique de Génétique, CHU Lille, Lille, France., Colas C; Department of Genetics, Curie Institute, Paris Sciences & Lettres Research University, Paris, France., Buisine MP; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France.
Publikováno v: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2023 Apr; Vol. 62 (4), pp. 210-222. Date of Electronic Publication: 2022 Dec 21.
Zobrazit plný text záznamu
5
Akademický článek
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective Study.
Autor: Bres C; Department of Digestive and Oncological Surgery, Claude Huriez Hospital, CHU Lille, France., Voron T; Department of Digestive Surgery, Sorbonne University, Saint-Antoine Hospital, APHP, Paris, France., Benhaim L; Department of Digestive Surgery, Gustave Roussy, Villejuif, France., Bergeat D; Department of Digestive Surgery, CHU Rennes, Rennes, France., Parc Y; Department of Digestive Surgery, Sorbonne University, Saint-Antoine Hospital, APHP, Paris, France., Karoui M; Department of Digestive Surgery, Georges Pompidou European Hospital, AP-HP, Paris, France., Genser L; Department of Digestive Surgery, Sorbonne University, Pitié-Salpétrière Hospital, APHP, Paris (France)., Péré G; Department of Digestive Surgery, CHU Toulouse, Toulouse, France., Demma JA; Department of Digestive Surgery, CHU Saint Louis, Paris, France., Bacoeur-Ouzillou O; Department of Digestive Surgery, CHU Clermont Ferrand, Clermont Ferrand, France., Lebreton G; Department of Digestive Surgery, CHU Caen, Caen, France., Thereaux J; Department of Digestive Surgery, CHU Brest, Brest, France., Gronnier C; Department of Digestive Surgery, CHU Bordeaux, Bordeaux, France., Dartigues P; Department of Pathology, Gustave Roussy, Villejuif, France., Svrcek M; Department of Pathology, Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Paris, France., Bouzillé G; Department of Medical Information, CHU Rennes, Rennes, France., Bardier A; Department of Digestive Surgery, Sorbonne University, Pitié-Salpétrière Hospital, APHP, Paris (France)., Brunac AC; Department of Pathology, Cancer University Institute of Toulouse Oncopole (IUCT); CHU Toulouse, France., Roche B; Department of Pathology, CHU Saint Louis, AP-HP, Paris, France., Darcha C; Department of Pathology, CHU Clermont Ferrand, Clermont Ferrand, France., Bazille C; Department of Pathology, CHU Caen, Caen, France., Doucet L; Department of Pathology, CHU Brest, Brest, France., Belleannee G; Department of Pathology, CHU Bordeaux, Bordeaux, France., Lejeune S; Department of Genetics, CHU Lille, Lille, France., Buisine MP; Department of Molecular Oncogenetics, CHU Lille, Lille, France.; Univ. Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Renaud F; Univ. Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Department of Pathology, Biology Pathology Center, Chu Lille - F-59000, Lille, France., Nuytens F; Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge Hospital, Kortrijk, Belgium., Benusiglio PR; Department of Digestive Surgery, Sorbonne University, Saint-Antoine Hospital, APHP, Paris, France.; UF of Clinical Oncogenetic, Departement of medical genetic and Universitary Institute of cancerology, Sorbonne University, Pitié-Salpêtrière Hospital, AP-HP, Paris (France)., Veziant J; Department of Digestive and Oncological Surgery, Claude Huriez Hospital, CHU Lille, France., Eveno C; Department of Digestive and Oncological Surgery, Claude Huriez Hospital, CHU Lille, France.; Univ. Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Piessen G; Department of Digestive and Oncological Surgery, Claude Huriez Hospital, CHU Lille, France.; Univ. Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
Publikováno v: Annals of surgery [Ann Surg] 2022 Nov 01; Vol. 276 (5), pp. 830-837. Date of Electronic Publication: 2022 Jul 20.
Zobrazit plný text záznamu
6
Akademický článek
Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B.
Autor: Carpenter J; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Wang Y; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Gupta R; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Li Y; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Haridass P; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Subramani DB; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Reidel B; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Morton L; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Ridley C; Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom.; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom., O'Neal WK; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Buisine MP; UMR9020-U1277 CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), Université Lille, CNRS, Inserm, CHU Lille, F5900 Lille, France., Ehre C; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248., Thornton DJ; Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom.; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom., Kesimer M; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248; kesimer@med.unc.edu.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Sep 28; Vol. 118 (39).
Zobrazit plný text záznamu
7
Akademický článek
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Autor: Ratovomanana T; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Cohen R; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Department of Medical Oncology, AP-HP, Hôpital Saint-Antoine, Paris, France., Svrcek M; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Department of Pathology, AP-HP, Hôpital Saint-Antoine, Paris, France., Renaud F; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France., Cervera P; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France., Siret A; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Letourneur Q; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Buhard O; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Bourgoin P; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Guillerm E; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France., Dorard C; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Nicolle R; Programme 'Cartes d'Identité des Tumeurs,' Ligue Nationale Contre le Cancer, Paris, France., Ayadi M; Programme 'Cartes d'Identité des Tumeurs,' Ligue Nationale Contre le Cancer, Paris, France., Touat M; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Service de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France., Bielle F; Service de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Département de Neuropathologie, Paris, France., Sanson M; Service de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Département de Neuropathologie, Paris, France., Le Rouzic P; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France., Buisine MP; Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Piessen G; Université de Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France; Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, University Lille, Lille, France., Collura A; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Fléjou JF; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Department of Pathology, AP-HP, Hôpital Saint-Antoine, Paris, France., de Reyniès A; Programme 'Cartes d'Identité des Tumeurs,' Ligue Nationale Contre le Cancer, Paris, France., Coulet F; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France., Ghiringhelli F; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France; INSERM, UMR866, Burgundy University, Dijon, France., André T; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Department of Medical Oncology, AP-HP, Hôpital Saint-Antoine, Paris, France., Jonchère V; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France., Duval A; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and Site de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine, University & Society (CURAMUS), Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne Université, Genetics Department, AP-HP, Hospital Pitié-Salpêtrière, Paris, France. Electronic address: alex.duval@inserm.fr.
Publikováno v: Gastroenterology [Gastroenterology] 2021 Sep; Vol. 161 (3), pp. 814-826.e7. Date of Electronic Publication: 2021 May 13.
Zobrazit plný text záznamu
8
Akademický článek
Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries.
Autor: Sina M; Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.; A. Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy., Ghorbanoghli Z; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. z.ghorbanoghli@gmail.com.; Dutch Hereditary Cancer Registry, Leiden, The Netherlands. z.ghorbanoghli@gmail.com., Abedrabbo A; Department of Pediatrics, Makassed Islamic Charitable Hospital, Jerusalem, Palestine., Al-Mulla F; Department of Genetics and Bioinformatics, Dasman Diabetes Institute, P.O. Box 1180, 15462, Dasman, Kuwait., Sghaier RB; Cytogenetic, Molecular Genetics and Human Reproduction Biology - Farhat, HACHED Hospital, Sousse, Tunisia., Buisine MP; Unit of Molecular Oncology and Genetics, Institute of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France., Cortas G; Department of Gastroenterology, St. George Hospital Medical Center, University of Balamand Medical School, Beirut, Lebanon., Goshayeshi L; Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Hadjisavvas A; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Hammoudeh W; Department of Internal Medicine, Arabcare Hospital, Ramallah, Palestine., Hamoudi W; Department of Gastroenterology, The Royal Hospital, Amman, Jordan., Jabari C; Patient's Friends Society, Jerusalem, Palestine.; Hebron University, Hebron, Palestine., Loizidou MA; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Majidzadeh-A K; Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran., Marafie MJ; Kuwait Medical Genetics Centre, Maternity Hospital, 13059, Safat, Kuwait., Muslumov G; Colorectal Surgery Department, Scientific Center of Surgery, Baku, Azerbaijan., Rifai L; Centre Hospitalier Universitaire IBN SINA, Rabat Instituts, Institut National D'Oncologie Sidi Mohamed Ben Abdellah, BP 6213, Rabat, Maroc., Seir RA; Al-Quds University, Abu-Dis, Palestine., Talaat SM; Ahmed Maher Teaching Hospital, Cairo, Egypt., Tunca B; Department of Medical Biology, Medical Faculty, Uludag University, Bursa, Turkey., Ziada-Bouchaar H; Laboratory of Biology and Molecular Genetics, Faculty of Medicine, University 3, Rabah Bitat, Constantine, Algeria., Velthuizen ME; Department of Genetics, University Medical Center Utrecht (Location WKZ), Utrecht, the Netherlands., Sharara AI; Division of Gastroenterology, American University of Beirut Medical Centre, Beirut, Lebanon., Ahadova A; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Georgiou D; Department of Clinical Genetics, London North West University Healthcare, London, UK., Vasen HFA; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Dutch Hereditary Cancer Registry, Leiden, The Netherlands.
Publikováno v: Familial cancer [Fam Cancer] 2021 Jul; Vol. 20 (3), pp. 215-221. Date of Electronic Publication: 2020 Oct 24.
Zobrazit plný text záznamu
9
Akademický článek
Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
Autor: Boulouard F; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.; Comprehensive Cancer Center François Baclesse, Laboratory of Cancer Biology and Genetics, Caen, France., Kasper E; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Buisine MP; Department of Biochemistry and Molecular Biology, Lille University Hospital Center, UMR 1277 Inserm-9020 CNRS, Lille University, Lille, France., Lienard G; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Vasseur S; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Manase S; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Bahuau M; Medical genetics Department, Henri Mondor Hospital, Créteil, France., Barouk Simonet E; Cancer Genetics Unit, Institut Bergonie, Bordeaux, France., Bubien V; Cancer Genetics Unit, Institut Bergonie, Bordeaux, France., Coulet F; Department of Genetics, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France., Cusin V; Department of Genetics, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France., Dhooge M; Gastroenterology Unit, Cochin University Hospital, Paris Descartes University, Paris, France., Golmard L; Institut Curie, Department of Genetics and Paris Sciences, Lettres Research University, Paris, France., Goussot V; Department of Tumor Biology and Pathology, Georges-François Leclerc Center, Dijon, France., Hamzaoui N; Department of Oncogenetics, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Lacaze E; Department of Genetics, Le Havre General Hospital, Normandy Centre for Genomic and Personalized Medicine, Le Havre, France., Lejeune S; Genetic Pathology Biology Department, Lille University Hospital Center, Jeanne de Flandre Hospital, Lille, France., Mauillon J; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Beaumont MP; Department of Genetics, Rennes University Hospital Center, Rennes, France., Pinson S; Genetics Department, Hospices Civils de LYON (HCL), University Hospital, East Pathology Center, Bron, France., Tlemsani C; Department of Oncogenetics, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Toulas C; Oncogenetic Laboratory, Cancer University Institute Toulouse Oncopole, Toulouse, France., Rey JM; Department of Pathology and Oncobiology, Montpellier University Hospital, Montpellier, France., Uhrhammer N; Centre Jean Perrin, Oncogenetics and Clermont Auvergne University, INSERM U1240, Clermont-Ferrand, France., Bougeard G; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Frebourg T; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Houdayer C; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France., Baert-Desurmont S; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.
Publikováno v: Clinical genetics [Clin Genet] 2021 May; Vol. 99 (5), pp. 662-672. Date of Electronic Publication: 2021 Feb 12.
Zobrazit plný text záznamu
10
Akademický článek
Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.
Autor: Leclerc J; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, CHU Lille, F-59000 Lille, France.; Univ. Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; CNRS, UMR9020, F-59000 Lille, France.; Inserm, U1277, F-59000 Lille, France., Vermaut C; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, CHU Lille, F-59000 Lille, France., Buisine MP; Molecular Oncogenetics, Department of Biochemistry and Molecular Biology, CHU Lille, F-59000 Lille, France.; Univ. Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.; CNRS, UMR9020, F-59000 Lille, France.; Inserm, U1277, F-59000 Lille, France.
Publikováno v: Cancers [Cancers (Basel)] 2021 Jan 26; Vol. 13 (3). Date of Electronic Publication: 2021 Jan 26.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje